193 related articles for article (PubMed ID: 11283930)
21. Features of gonadal dysgenesis and Leydig cell impairment in testes with Sertoli cell-only syndrome.
Adamczewska D; Slowikowska-Hilczer J; Marchlewska K; Walczak-Jedrzejowska R
Folia Histochem Cytobiol; 2020; 58(2):73-82. PubMed ID: 32490535
[TBL] [Abstract][Full Text] [Related]
22. Decrease in semen quality and Leydig cell function in infertile men: a longitudinal study.
Olesen IA; Joensen UN; Petersen JH; Almstrup K; Rajpert-De Meyts E; Carlsen E; McLachlan R; Juul A; Jørgensen N
Hum Reprod; 2018 Nov; 33(11):1963-1974. PubMed ID: 30247578
[TBL] [Abstract][Full Text] [Related]
23. [Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study].
Kreuser ED; Kurrle E; Hetzel WD; Heymer B; Porzsolt F; Hautmann R; Gaus W; Schlipf U; Pfeiffer EF; Heimpel H
Klin Wochenschr; 1989 Apr; 67(7):367-78. PubMed ID: 2501552
[TBL] [Abstract][Full Text] [Related]
24. Serum gonadotropin levels in patients with germ-cell tumors of the testis: interrelations, possible cross-reactions and interpretation of beta-HCG level.
Kovcin VN; Jelić SB; Ivanović SM; Babović NL
Int J Biol Markers; 1997; 12(2):55-60. PubMed ID: 9342633
[TBL] [Abstract][Full Text] [Related]
25. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
26. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
[TBL] [Abstract][Full Text] [Related]
27. Endocrinological late effects after chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schuppert F; Schmoll HJ
Br J Cancer; 1996 May; 73(9):1108-14. PubMed ID: 8624272
[TBL] [Abstract][Full Text] [Related]
28. Gonadal status in male survivors following childhood brain tumors.
Schmiegelow M; Lassen S; Poulsen HS; Schmiegelow K; Hertz H; Andersson AM; Skakkebaek NE; Müller J
J Clin Endocrinol Metab; 2001 Jun; 86(6):2446-52. PubMed ID: 11397837
[TBL] [Abstract][Full Text] [Related]
29. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients.
Giwercman A; von der Maase H; Berthelsen JG; Rørth M; Bertelsen A; Skakkebaek NE
J Clin Endocrinol Metab; 1991 Sep; 73(3):596-603. PubMed ID: 1908483
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
[TBL] [Abstract][Full Text] [Related]
31. Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis.
Tsatsoulis A; Shalet SM; Morris ID; de Kretser DM
Horm Res; 1990; 34(5-6):254-9. PubMed ID: 2129227
[TBL] [Abstract][Full Text] [Related]
32. Gonadal dysfunction in patients treated for metastatic germ-cell tumors.
Leitner SP; Bosl GJ; Bajorunas D
J Clin Oncol; 1986 Oct; 4(10):1500-5. PubMed ID: 3020183
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
Sprauten M; Brydøy M; Haugnes HS; Cvancarova M; Bjøro T; Bjerner J; Fosså SD; Oldenburg J
J Clin Oncol; 2014 Feb; 32(6):571-8. PubMed ID: 24419125
[TBL] [Abstract][Full Text] [Related]
34. Altered Leydig cell function in patients with testicular cancer: evidence for bilateral testicular defect.
Willemse PH; Sleijfer DT; Sluiter WJ; Schraffordt Koops H; Doorenbos H
Acta Endocrinol (Copenh); 1983 Apr; 102(4):616-24. PubMed ID: 6133401
[TBL] [Abstract][Full Text] [Related]
35. Reference intervals for serum sex hormones in Han Chinese adult men from the Fangchenggang Area Male Health and Examination Survey.
Qin X; Lv H; Mo Z; Chen Z; Lin L; Peng T; Zhang H; Yang X; Gao Y; Tan A; Huang S; Li H; Wu H; Deng Y; Li S
Clin Lab; 2012; 58(3-4):281-90. PubMed ID: 22582502
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer.
Petersen PM; Hansen SW; Giwercman A; Rørth M; Skakkebaek NE
Ann Oncol; 1994 Apr; 5(4):355-8. PubMed ID: 8075033
[TBL] [Abstract][Full Text] [Related]
37. Establishing reference intervals for sex hormones and SHBG in apparently healthy Chinese adult men based on a multicenter study.
Yu S; Qiu L; Liu M; Li S; Tao Z; Zhang Q; Xia L; Li P; Hou L; Qin X; Yin Y; Ichihara K; Cheng X
Clin Chem Lab Med; 2018 Jun; 56(7):1152-1160. PubMed ID: 29729137
[TBL] [Abstract][Full Text] [Related]
38. Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Eur J Cancer; 2017 Oct; 84():9-17. PubMed ID: 28772110
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH.
Bruheim K; Svartberg J; Carlsen E; Dueland S; Haug E; Skovlund E; Tveit KM; Guren MG
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):722-7. PubMed ID: 18262088
[TBL] [Abstract][Full Text] [Related]
40. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
